J&J Tells Fed. Circ. Judge Was Wrong To Nix Zytiga Patent
A district court judge was wrong to invalidate a patent for a Johnson & Johnson unit's blockbuster cancer drug Zytiga, the company told the Federal Circuit, arguing that the lower court...To view the full article, register now.
Already a subscriber? Click here to view full article